News - Sanofi, GlaxoSmithKline


Current filters:


Popular Filters

Pharma figures high in EU R&D Investment Scoreboard, but led by US firms


Though not topping the league table, the pharmaceutical industry had a number of drugmakers among the…

EuropeFinancialGlaxoSmithKlineJohnson & JohnsonMerck & CoNorth AmericaNovartisPfizerPharmaceuticalResearchRocheSanofi

Morningstar analysts find GlaxoSmithKline has strongest pipeline

Morningstar analysts find GlaxoSmithKline has strongest pipeline


Morningstar, an independent Chicago-based investment research firm, recently published the November 2013…

AbbVieAstraZenecaBayerFinancialGlaxoSmithKlineMerck & CoPharmaceuticalResearchSanofi

Japan's seasonal flu vaccines market analysis


The Japanese influenza vaccine market is valued at around $702 million in 2012, according to a new report…

Anti-viralsAsia-PacificGlaxoSmithKlineMarkets & MarketingPharmaceuticalSanofiVaccines

News briefs from Sanofi, Bayer, GlaxoSmithKline and Novartis


French drug major Sanofi (Euronext: SAN) has entered into a binding agreement to acquire the animal health…

BayerDosch PharmaceuticalsExjadeFlonaseGlaxoSmithKlineLegalMergers & AcquisitionsMerialNovartisOncologyPharmaceuticalregorafenibRegulationRespiratory and PulmonarySanofi

News briefs on Sanofi, Novo Nordisk and GlaxoSmithKline/Amicus


Two US subsidiaries of French drug major Sanofi (Euronext: SAN) have agreed to pay $109 million to resolve…

Amicus TherapeuticsAmigalDiabetesFIAspFinancialGlaxoSmithKlineHyalganIDegLiraLegalNorth AmericaNovo NordiskPharmaceuticalRare diseasesResearchSanofi

Five more drug majors join NIH initiative to speed therapeutic discovery


Five additional pharmaceutical companies have joined a US National Institutes of Health-led effort to…

Abbott LaboratoriesBristol-Myers SquibbGlaxoSmithKlineJohnson & JohnsonNorth AmericaPharmaceuticalResearchSanofi

Gap in patent filings for biological and small-molecule drugs widening, says Withers & Rogers


The number of patent applications filed by leading pharmaceutical companies for biological drugs has…

Abbott LaboratoriesBiotechnologyGlaxoSmithKlineNovartisPatentsPfizerPharmaceuticalResearchSanofi

UK government to switch from Cervarix to Gardasil for HPV vaccination


As of next September, a different vaccine will be used in the HPV vaccination program to protect girls…

CervarixEuropeGardasilGlaxoSmithKlineHealthcareMerck & CoOncologyPharmaceuticalPricingSanofiSanofi Pasteur MSDVaccinesWomen's Health

EU Pharma re-rating stalled against EU market vis-a-vis defensives, says Nomura analyst


While European Union Pharma has outperformed the EU market by 16% year-to-date, the corresponding performance…


Back to top